A Phase I Study to Assess the Safety and Immunogenicity of AdCh3NSmut and MVA-NSmut in Healthy Volunteers and Patients With Hepatitis C Virus Infection
Phase of Trial: Phase I
Latest Information Update: 26 Jul 2016
At a glance
- Drugs Hepatitis C vaccine (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors ReiThera
- 24 Apr 2016 Status changed from active, no longer recruiting to completed.
- 23 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to United Kingdom Clinical Research Network record.
- 02 Apr 2015 Planned End Date changed from 1 Mar 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.